Your browser doesn't support javascript.
loading
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction.
Tribble, James R; Otmani, Amin; Sun, Shanshan; Ellis, Sevannah A; Cimaglia, Gloria; Vohra, Rupali; Jöe, Melissa; Lardner, Emma; Venkataraman, Abinaya P; Domínguez-Vicent, Alberto; Kokkali, Eirini; Rho, Seungsoo; Jóhannesson, Gauti; Burgess, Robert W; Fuerst, Peter G; Brautaset, Rune; Kolko, Miriam; Morgan, James E; Crowston, Jonathan G; Votruba, Marcela; Williams, Pete A.
Afiliação
  • Tribble JR; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: james.tribble@ki.se.
  • Otmani A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: amin.otmani@ki.se.
  • Sun S; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK. Electronic address: SunS9@cardiff.ac.uk.
  • Ellis SA; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia. Electronic address: ellissa@student.unimelb.edu.au.
  • Cimaglia G; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK. Electronic address: CimagliaG@cardiff.ac.uk.
  • Vohra R; Department of Veterinary and Animal Sciences, Pathobiological Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Department of Drug Design and Pharmacology, Eye Translational Research Unit, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. E
  • Jöe M; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: melissa.joe@ki.se.
  • Lardner E; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: emma.lardner@sll.se.
  • Venkataraman AP; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: abinaya.venkataraman@ki.se.
  • Domínguez-Vicent A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: alberto.dominguez.vicent@ki.se.
  • Kokkali E; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK. Electronic address: KokkaliE@cardiff.ac.uk.
  • Rho S; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK; Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. Electronic address: harryrho@gmail.com.
  • Jóhannesson G; Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden; Wallenberg Centre of Molecular Medicine, Umeå University, Umeå, Sweden. Electronic address: gauti.johannesson@umu.se.
  • Burgess RW; The Jackson Laboratory, Bar Harbor, ME, USA. Electronic address: Robert.Burgess@jax.org.
  • Fuerst PG; WWAMI Medical Education Program, University of Idaho, Moscow, ID, USA. Electronic address: fuerst@uidaho.edu.
  • Brautaset R; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: Rune.Brautaset@ki.se.
  • Kolko M; Department of Drug Design and Pharmacology, Eye Translational Research Unit, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet-Glostrup, Glostrup, Denmark. Electronic address: miriamk@sund.ku.dk.
  • Morgan JE; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK; Cardiff Eye Unit, University Hospital Wales, Cardiff, UK; School of Medicine, Cardiff University, Cardiff, UK. Electronic address: MorganJE3@cardiff.ac.uk.
  • Crowston JG; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore; Centre for Vision Research, Neuroscience and Behavioural Disorders, Duke-NUS, Singapore, Singapore. Electronic address
  • Votruba M; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK; Cardiff Eye Unit, University Hospital Wales, Cardiff, UK. Electronic address: VotrubaM@cardiff.ac.uk.
  • Williams PA; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: pete.williams@ki.se.
Redox Biol ; 43: 101988, 2021 07.
Article em En | MEDLINE | ID: mdl-33932867
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glaucoma / Doenças Neurodegenerativas Limite: Animals / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glaucoma / Doenças Neurodegenerativas Limite: Animals / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2021 Tipo de documento: Article